Bausch Health
BHC
#4626
Rank
ยฃ1.55 B
Marketcap
ยฃ4.19
Share price
2.68%
Change (1 day)
-30.15%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): ยฃ0.72

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is ยฃ0.71. In 2024 the company made an earnings per share (EPS) of -ยฃ0.08769 an increase over its 2023 EPS that were of -ยฃ1.18.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.72-925.41%
2024-ยฃ0.08769-92.59%
2023-ยฃ1.18160.89%
2022-ยฃ0.45-76.64%
2021-ยฃ1.9468.45%
2020-ยฃ1.15-68.91%
2019-ยฃ3.71-57.11%
2018-ยฃ8.65-272.22%
2017ยฃ5.02-199.29%
2016-ยฃ5.06798.7%
2015-ยฃ0.56-128.31%
2014ยฃ1.99-204.62%
2013-ยฃ1.90602.7%
2012-ยฃ0.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.18-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.69-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA